@inproceedings{inproceedings, title = {{Tumour xenograft regression can be induced by combining the vascular-targeting agent ZD6126 with the VEGF receptor tyrosine kinase inhibitor ZD6474.}}, url = {{}}, year = {{2002}}, month = {{1}}, author = {{Ryan AJ and Kendrew J and Ogilvie DJ and Hennequin LF and Brave SR and Ashton SE and Calvete JA and Blakey DC and Wedge SR}}, volume = {{86}}, journal = {{BRITISH JOURNAL OF CANCER}}, pages = {{S99-S100}}, note = {{Accessed on 2025/05/31}}}